Data & APIsEventsMarketfyPremarketBoost
Contribute Login Join
Data & APIs
Events
Marketfy
Premarket
Boost

Simrat Randhawa Net Worth & Insider Trades

Simrat Randhawa - Chief Medical Officer, Dianthus Therapeutics, Inc

As of September 25, 2023

What is Simrat Randhawa's Net Worth?

The current estimated net worth of Dianthus Therapeutics, Inc's Chief Medical Officer, Simrat Randhawa, is estimated to be about $50.04K . Simrat Randhawa owns about 4,000 units of Dianthus Therapeutics, Inc common stock. Recently at Dianthus Therapeutics, Inc, Simrat Randhawa has sold an estimated value of $0 worth.

What is Simrat Randhawa's Past Insider Trading?

Simrat Randhawa's largest purchase order was 4,000 units , worth over $52.8K on September 25, 2023. In total, Simrat Randhawa has made about 1 transaction recently at Dianthus Therapeutics, Inc. Simrat Randhawa usually trades in September, with the busiest year in 2023.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Simrat Randhawa

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Simrat Randhawa's' Mailing Address?

  • Mailing address is 7 Times Square 43rd Floor New York NY 10036 NY

What are Dianthus Therapeutics, Inc's Past Insider Trades?

Dianthus Therapeutics, Inc's most recent insider trade came on October 3, 2023 by Fairmount Funds Management Llc, Tomas Kiselak and Evan Peter Harwin who bought 24,670 units worth $336.25K . In the last month, insiders at Dianthus Therapeutics, Inc have bought an estimated value of $0 worth of shares. Insider trading is most common in September, with the busiest year in 2023. The most active traders at the company are Evan Peter Harwin, Director,  Fairmount Funds Management Llc, Director,  and Tomas Kiselak, Director .

Dianthus Therapeutics, Inc. /DE/ Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...